-
1
-
-
84859052757
-
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
-
T. Beach, S. Monsell, L. Phillips, W. Kukull, Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J. Neuropathol. Exp. Neurol. 71, 266-273 (2012).
-
(2012)
J. Neuropathol. Exp. Neurol.
, vol.71
, pp. 266-273
-
-
Beach, T.1
Monsell, S.2
Phillips, L.3
Kukull, W.4
-
2
-
-
0030805991
-
Frequency of stages of Alzheimer-related lesions in different age categories
-
H. Braak, E. Braak, Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351-357 (1997).
-
(1997)
Neurobiol. Aging
, vol.18
, pp. 351-357
-
-
Braak, H.1
Braak, E.2
-
3
-
-
0029979798
-
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
-
T. Gómez-Isla, J. Price, D. McKeel, J. Morris, J. Growdon, B. Hyman, Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500 (1996).
-
(1996)
J. Neurosci.
, vol.16
, pp. 4491-4500
-
-
Gómez-Isla, T.1
Price, J.2
McKeel, D.3
Morris, J.4
Growdon, J.5
Hyman, B.6
-
4
-
-
0031593785
-
Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals
-
C. M. Hulette, K. A. Welsh-Bohmer, M. G. Murray, A. M. Saunders, D. C. Mash, L. M. McIntyre, Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 57, 1168-1174 (1998).
-
(1998)
J. Neuropathol. Exp. Neurol.
, vol.57
, pp. 1168-1174
-
-
Hulette, C.M.1
Welsh-Bohmer, K.A.2
Murray, M.G.3
Saunders, A.M.4
Mash, D.C.5
McIntyre, L.M.6
-
5
-
-
30344469658
-
Neuropathologic substrate of mild cognitive impairment
-
W. Markesbery, F. Schmitt, R. Kryscio, D. Davis, C. Smith, D. Wekstein, Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 63, 38-46 (2006).
-
(2006)
Arch. Neurol.
, vol.63
, pp. 38-46
-
-
Markesbery, W.1
Schmitt, F.2
Kryscio, R.3
Davis, D.4
Smith, C.5
Wekstein, D.6
-
6
-
-
0035168927
-
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
-
J. Morris, J. Price, Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17, 101-118 (2001).
-
(2001)
J. Mol. Neurosci.
, vol.17
, pp. 101-118
-
-
Morris, J.1
Price, J.2
-
7
-
-
0034849725
-
Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease
-
J. Price, A. Ko, M. Wade, S. Tsou, D. McKeel, J. Morris, Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer's disease. Arch. Neurol. 58, 1395-1402 (2001).
-
(2001)
Arch. Neurol.
, vol.58
, pp. 1395-1402
-
-
Price, J.1
Ko, A.2
Wade, M.3
Tsou, S.4
McKeel, D.5
Morris, J.6
-
8
-
-
70350061949
-
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
-
R. Perrin, A. Fagan, D. Holtzman, Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922 (2009).
-
(2009)
Nature
, vol.461
, pp. 916-922
-
-
Perrin, R.1
Fagan, A.2
Holtzman, D.3
-
9
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
C. Jack, D. Knopman, W. Jagust, L. Shaw, P. Aisen, M. Weiner, R. Petersen, J. Trojanowski, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010).
-
(2010)
Lancet Neurol.
, vol.9
, pp. 119-128
-
-
Jack, C.1
Knopman, D.2
Jagust, W.3
Shaw, L.4
Aisen, P.5
Weiner, M.6
Petersen, R.7
Trojanowski, J.8
-
10
-
-
33644832047
-
42 in humans
-
42 in humans. Ann. Neurol. 59, 512-519 (2006).
-
(2006)
Ann. Neurol.
, vol.59
, pp. 512-519
-
-
Fagan, A.1
Mintun, M.2
Mach, R.3
Lee, S.-Y.4
Dence, C.5
Shah, A.6
La Rossa, G.7
Spinner, M.8
Klunk, W.9
Mathis, C.10
De Kosky, S.11
Morris, J.12
Holtzman, D.13
-
11
-
-
67349227896
-
Beta amyloid in Alzheimer's disease: Increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid
-
T. Grimmer, M. Riemenschneider, H. Förstl, G. Henriksen, W. Klunk, C. Mathis, T. Shiga, H. Wester, A. Kurz, A. Drzezga, Beta amyloid in Alzheimer's disease: Increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol. Psychiatry 65, 927-934 (2009).
-
(2009)
Biol. Psychiatry
, vol.65
, pp. 927-934
-
-
Grimmer, T.1
Riemenschneider, M.2
Förstl, H.3
Henriksen, G.4
Klunk, W.5
Mathis, C.6
Shiga, T.7
Wester, H.8
Kurz, A.9
Drzezga, A.10
-
12
-
-
69449085355
-
18F-FDDNP binding
-
18F-FDDNP binding. J. Nucl. Med. 50, 1464-1470 (2009).
-
(2009)
J. Nucl. Med.
, vol.50
, pp. 1464-1470
-
-
Tolboom, N.1
Van Der Flier, W.2
Yaqub, M.3
Boellaard, R.4
Verwey, N.5
Blankenstein, M.6
Windhorst, A.7
Scheltens, P.8
Lammertsma, A.9
Van Berckel, B.10
-
13
-
-
70350152831
-
Alzheimer's Disease Neuroimaging Initiative, Relationships between biomarkers in aging and dementia
-
W. Jagust, S. Landau, L. Shaw, J. Trojanowski, R. Koeppe, E. Reiman, N. Foster, R. Petersen, M. Weiner, J. Price, C. Mathis; Alzheimer's Disease Neuroimaging Initiative, Relationships between biomarkers in aging and dementia. Neurology 73, 1193-1199 (2009).
-
(2009)
Neurology
, vol.73
, pp. 1193-1199
-
-
Jagust, W.1
Landau, S.2
Shaw, L.3
Trojanowski, J.4
Koeppe, R.5
Reiman, E.6
Foster, N.7
Petersen, R.8
Weiner, M.9
Price, J.10
Mathis, C.11
-
14
-
-
62449262536
-
Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
-
T. Tapiola, I. Alafuzoff, S. Herukka, L. Parkkinen, P. Hartikainen, H. Soininen, T. Pirttilä, Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol. 66, 382-389 (2009).
-
(2009)
Arch. Neurol.
, vol.66
, pp. 382-389
-
-
Tapiola, T.1
Alafuzoff, I.2
Herukka, S.3
Parkkinen, L.4
Hartikainen, P.5
Soininen, H.6
Pirttilä, T.7
-
15
-
-
0346124139
-
Cerebrospinal fluid tau and β-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
-
C. Clark, S. Xie, J. Chittams, D. Ewbank, E. Peskind, D. Galasko, J. Morris, D. McKeel, M. Farlow, S. Weitlauf, J. Quinn, J. Kaye, D. Knopman, H. Arai, R. Doody, C. DeCarli, S. Leight, V. Lee, J. Trojanowski, Cerebrospinal fluid tau and β-amyloid: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch. Neurol. 60, 1696-1702 (2003).
-
(2003)
Arch. Neurol.
, vol.60
, pp. 1696-1702
-
-
Clark, C.1
Xie, S.2
Chittams, J.3
Ewbank, D.4
Peskind, E.5
Galasko, D.6
Morris, J.7
McKeel, D.8
Farlow, M.9
Weitlauf, S.10
Quinn, J.11
Kaye, J.12
Knopman, D.13
Arai, H.14
Doody, R.15
De Carli, C.16
Leight, S.17
Lee, V.18
Trojanowski, J.19
-
16
-
-
0037465449
-
CSF Aβ 42 levels correlate with amyloidneuropathology in a population-based autopsy study
-
D. Strozyk, K. Blennow, L. White, L. Launer, CSF Aβ 42 levels correlate with amyloidneuropathology in a population-based autopsy study. Neurology 60, 652-656 (2003).
-
(2003)
Neurology
, vol.60
, pp. 652-656
-
-
Strozyk, D.1
Blennow, K.2
White, L.3
Launer, L.4
-
17
-
-
20844432024
-
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease
-
H. Hampel, K. Bürger, J. Pruessner, R. Zinkowski, J. DeBernardis, D. Kerkman, G. Leinsinger, A. Evans, P. Davies, H.-J. Möller, T. Stefan, Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch. Neurol. 62, 770-773 (2005).
-
(2005)
Arch. Neurol.
, vol.62
, pp. 770-773
-
-
Hampel, H.1
Bürger, K.2
Pruessner, J.3
Zinkowski, R.4
De Bernardis, J.5
Kerkman, D.6
Leinsinger, G.7
Evans, A.8
Davies, P.9
Möller, H.-J.10
Stefan, T.11
-
18
-
-
84868114377
-
Alzheimer's Disease Neuroimaging Initiative, Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers
-
M. Lehmann, E. Koedam, J. Barnes, J. Bartlett, F. Barkhof, M. Wattjes, J. Schott, P. Scheltens, N. Fox; Alzheimer's Disease Neuroimaging Initiative, Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiol. Aging 34, 73-82 (2013).
-
(2013)
Neurobiol. Aging
, vol.34
, pp. 73-82
-
-
Lehmann, M.1
Koedam, E.2
Barnes, J.3
Bartlett, J.4
Barkhof, F.5
Wattjes, M.6
Schott, J.7
Scheltens, P.8
Fox, N.9
-
19
-
-
0031583947
-
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease
-
T. Tapiola, M. Overmyer, M. Lehtovirta, S. Helisalmi, J. Ramberg, I. Alafuzoff, P. Riekkinen, H. Soininen, The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease. Neuroreport 8, 3961-3963 (1997).
-
(1997)
Neuroreport
, vol.8
, pp. 3961-3963
-
-
Tapiola, T.1
Overmyer, M.2
Lehtovirta, M.3
Helisalmi, S.4
Ramberg, J.5
Alafuzoff, I.6
Riekkinen, P.7
Soininen, H.8
-
20
-
-
33750589818
-
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
-
K. Buerger, M. Ewers, T. Pirttilä, R. Zinkowski, I. Alafuzoff, S. J. Teipel, J. DeBernardis, D. Kerkman, C. McCulloch, H. Soininen, H. Hampel, CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129, 3035-3041 (2006).
-
(2006)
Brain
, vol.129
, pp. 3035-3041
-
-
Buerger, K.1
Ewers, M.2
Pirttilä, T.3
Zinkowski, R.4
Alafuzoff, I.5
Teipel, S.J.6
De Bernardis, J.7
Kerkman, D.8
McCulloch, C.9
Soininen, H.10
Hampel, H.11
-
21
-
-
34548292987
-
4, plaque and tangle burden in definite Alzheimer's disease
-
4, plaque and tangle burden in definite Alzheimer's disease. Brain 130, 2320-2326 (2007).
-
(2007)
Brain
, vol.130
, pp. 2320-2326
-
-
Engelborghs, S.1
Sleegers, K.2
Cras, P.3
Brouwers, N.4
Serneels, S.5
Leenheir, E.D.6
Martin, J.7
Vanmechelen, E.8
Van Broeckhoven, C.9
De Deyn, P.10
-
22
-
-
84865529158
-
Dominantly Inherited Alzheimer Network, Clinical and biomarker changes in dominantly inherited Alzheimer's disease
-
R. J. Bateman, C. Xiong, T. L. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, J. C. Morris; Dominantly Inherited Alzheimer Network, Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795-804 (2012).
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 795-804
-
-
Bateman, R.J.1
Xiong, C.2
Benzinger, T.L.3
Fagan, A.M.4
Goate, A.5
Fox, N.C.6
Marcus, D.S.7
Cairns, N.J.8
Xie, X.9
Blazey, T.M.10
Holtzman, D.M.11
Santacruz, A.12
Buckles, V.13
Oliver, A.14
Moulder, K.15
Aisen, P.S.16
Ghetti, B.17
Klunk, W.E.18
McDade, E.19
Martins, R.N.20
Masters, C.L.21
Mayeux, R.22
Ringman, J.M.23
Rossor, M.N.24
Schofield, P.R.25
Sperling, R.A.26
Salloway, S.27
Morris, J.C.28
more..
-
23
-
-
33845439412
-
The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers
-
J. Morris, S. Weintraub, H. Chui, J. Cummings, C. Decarli, S. Ferris, N. Foster, D. Galasko, N. Graff-Radford, E. Peskind, D. Beekly, E. Ramos, W. Kukull, The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis. Assoc. Disord. 20, 210-216 (2006).
-
(2006)
Alzheimer Dis. Assoc. Disord.
, vol.20
, pp. 210-216
-
-
Morris, J.1
Weintraub, S.2
Chui, H.3
Cummings, J.4
Decarli, C.5
Ferris, S.6
Foster, N.7
Galasko, D.8
Graff-Radford, N.9
Peskind, E.10
Beekly, D.11
Ramos, E.12
Kukull, W.13
-
24
-
-
80052775337
-
181 for identifying Alzheimer disease amyloid plaque pathology
-
181 for identifying Alzheimer disease amyloid plaque pathology. Arch. Neurol. 68, 1137-1144 (2011).
-
(2011)
Arch. Neurol.
, vol.68
, pp. 1137-1144
-
-
Fagan, A.1
Shaw, L.2
Xiong, C.3
Vanderstichele, H.4
Mintun, M.5
Trojanowski, J.6
Coart, E.7
Morris, J.8
Holtzman, D.9
-
25
-
-
42649128419
-
Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study
-
P. Lewczuk, J. Kornhuber, H. Vanderstichele, E. Vanmechelen, H. Esselmann, M. Bibl, S. Wolf, M. Otto, U. Reulbach, H. Kölsch, F. Jessen, J. Schröder, P. Schönknecht, H. Hampel, O. Peters, E. Weimer, R. Perneczky, H. Jahn, C. Luckhaus, U. Lamla, T. Supprian, J. Maler, J. Wiltfang, Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: A multicenter study. Neurobiol. Aging 29, 812-818 (2008).
-
(2008)
Neurobiol. Aging
, vol.29
, pp. 812-818
-
-
Lewczuk, P.1
Kornhuber, J.2
Vanderstichele, H.3
Vanmechelen, E.4
Esselmann, H.5
Bibl, M.6
Wolf, S.7
Otto, M.8
Reulbach, U.9
Kölsch, H.10
Jessen, F.11
Schröder, J.12
Schönknecht, P.13
Hampel, H.14
Peters, O.15
Weimer, E.16
Perneczky, R.17
Jahn, H.18
Luckhaus, C.19
Lamla, U.20
Supprian, T.21
Maler, J.22
Wiltfang, J.23
more..
-
27
-
-
78149330220
-
Biomarkers in Alzheimer's disease drug development
-
K. Blennow, Biomarkers in Alzheimer's disease drug development. Nat. Med. 16, 1218-1222 (2010).
-
(2010)
Nat. Med.
, vol.16
, pp. 1218-1222
-
-
Blennow, K.1
-
28
-
-
0037514257
-
1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease
-
1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer's disease. JAMA 289, 2094-2103 (2003).
-
(2003)
JAMA
, vol.289
, pp. 2094-2103
-
-
Sunderland, T.1
Linker, G.2
Mirza, N.3
Putnam, K.4
Friedman, D.5
Kimmel, L.6
Bergeson, J.7
Manetti, G.8
Zimmermann, M.9
Tang, B.10
Bartko, J.11
Cohen, R.12
-
29
-
-
79960764322
-
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
-
N. Mattsson, U. Andreasson, S. Persson, H. Arai, S. Batish, S. Bernardini, L. Bocchio-Chiavetto, M. Blankenstein, M. Carrillo, S. Chalbot, E. Coart, D. Chiasserini, N. Cutler, G. Dahlfors, S. Duller. A. Fagan, O. Forlenza, G. Frisoni, D. Galasko, D. Galimberti, H. Hampel, A. Handberg, M. Heneka, A. Herskovits, S. Herukka, D. Holtzman, C. Humpel, B. Hyman, K. Iqbal, M. Jucker, S. Kaeser, E. Kaiser, E. Kapaki, D. Kidd, P. Klivenyi, C. Knudsen, M. Kummer, J. Lui, A. Lladó, P. Lewczuk, Q. Li, R. Martins, C. Masters, J. McAuliffe, M. Mercken, A. Moghekar, J. Molinuevo, T. Montine, W. Nowatzke, R. O'Brien, M. Otto, G. Paraskevas, L. Parnetti, R. Petersen, D. Prvulovic, H. De Reus, R. Rissman, E. Scarpini, A. Stefani, H. Soininen, J. Schröder, L. Shaw, A. Skinningsrud, B. Skrogstad, A. Spreer, L. Talib, C. Teunissen, J. Trojanowski, H. Tumani, R. Umek, B. Broeck, H. Vanderstichele, L. Vecsei, M. Verbeek, M. Windisch, J. Zhang, H. Zetterberg, K. Blennow, The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 7, 386-395 (2011).
-
(2011)
Alzheimers Dement.
, vol.7
, pp. 386-395
-
-
Mattsson, N.1
Andreasson, U.2
Persson, S.3
Arai, H.4
Batish, S.5
Bernardini, S.6
Bocchio-Chiavetto, L.7
Blankenstein, M.8
Carrillo, M.9
Chalbot, S.10
Coart, E.11
Chiasserini, D.12
Cutler, N.13
Dahlfors, G.14
Duller, S.15
Fagan, A.16
Forlenza, O.17
Frisoni, G.18
Galasko, D.19
Galimberti, D.20
Hampel, H.21
Handberg, A.22
Heneka, M.23
Herskovits, A.24
Herukka, S.25
Holtzman, D.26
Humpel, C.27
Hyman, B.28
Iqbal, K.29
Jucker, M.30
Kaeser, S.31
Kaiser, E.32
Kapaki, E.33
Kidd, D.34
Klivenyi, P.35
Knudsen, C.36
Kummer, M.37
Lui, J.38
Lladó, A.39
Lewczuk, P.40
Li, Q.41
Martins, R.42
Masters, C.43
McAuliffe, J.44
Mercken, M.45
Moghekar, A.46
Molinuevo, J.47
Montine, T.48
Nowatzke, W.49
O'Brien, R.50
Otto, M.51
Paraskevas, G.52
Parnetti, L.53
Petersen, R.54
Prvulovic, D.55
De Reus, H.56
Rissman, R.57
Scarpini, E.58
Stefani, A.59
Soininen, H.60
Schröder, J.61
Shaw, L.62
Skinningsrud, A.63
Skrogstad, B.64
Spreer, A.65
Talib, L.66
Teunissen, C.67
Trojanowski, J.68
Tumani, H.69
Umek, R.70
Broeck, B.71
Vanderstichele, H.72
Vecsei, L.73
Verbeek, M.74
Windisch, M.75
Zhang, J.76
Zetterberg, H.77
Blennow, K.78
more..
-
30
-
-
84876909712
-
Alzheimer's Association QC Program Work Group, CSF biomarker variability in the Alzheimer's Association quality control program
-
N. Mattsson, U. Andreasson, S. Persson, M. Carrillo, S. Collins, S. Chalbot, N. Cutler, D. Dufour-Rainfray, A. Fagan, H. Heegaard, G. Robin-Hsiung, B. Hyman, K. Iqbal, D. Lachno, A. Lleó, P. Lewczuk, J. Molinuevo, P. Parchi, A. Regeniter, R. Rissman, H. Rosenmann, G. Sancesario, J. Schröder, L. Shaw, C. Teunissen, J. Trojanowski, H. Vanderstichele, M. Vandijck, M. Verbeek, H. Zetterberg, K. Blennow, S. Käser; Alzheimer's Association QC Program Work Group, CSF biomarker variability in the Alzheimer's Association quality control program. Alzheimers Dement. 9, 251-261 (2013).
-
(2013)
Alzheimers Dement.
, vol.9
, pp. 251-261
-
-
Mattsson, N.1
Andreasson, U.2
Persson, S.3
Carrillo, M.4
Collins, S.5
Chalbot, S.6
Cutler, N.7
Dufour-Rainfray, D.8
Fagan, A.9
Heegaard, H.10
Robin-Hsiung, G.11
Hyman, B.12
Iqbal, K.13
Lachno, D.14
Lleó, A.15
Lewczuk, P.16
Molinuevo, J.17
Parchi, P.18
Regeniter, A.19
Rissman, R.20
Rosenmann, H.21
Sancesario, G.22
Schröder, J.23
Shaw, L.24
Teunissen, C.25
Trojanowski, J.26
Vanderstichele, H.27
Vandijck, M.28
Verbeek, M.29
Zetterberg, H.30
Blennow, K.31
Käser, S.32
more..
-
31
-
-
78349265011
-
(1-42), tau, and phosphorylated tau in Alzheimer's disease: Report of an international workshop
-
(1-42), tau, and phosphorylated tau in Alzheimer's disease: Report of an international workshop. Int. J. Alzheimers Dis. 2010, 635053 (2010).
-
(2010)
Int. J. Alzheimers Dis.
, vol.2010
, pp. 635053
-
-
Teunissen, C.1
Verwey, N.2
Kester, M.3
Van Uffelen, K.4
Blankenstein, M.5
-
32
-
-
0020333131
-
Random-effects models for longitudinal data
-
N. Laird, J. Ware, Random-effects models for longitudinal data. Biometrics 38, 963-974 (1982).
-
(1982)
Biometrics
, vol.38
, pp. 963-974
-
-
Laird, N.1
Ware, J.2
-
33
-
-
84891481919
-
Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN)
-
M. Storandt, D. Balota, A. Aschenbrenner, J. Morris, Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology 28, 19-29 (2014).
-
(2014)
Neuropsychology
, vol.28
, pp. 19-29
-
-
Storandt, M.1
Balota, D.2
Aschenbrenner, A.3
Morris, J.4
-
36
-
-
78650678688
-
Decreased clearance of CNS β-amyloid in Alzheimer's disease
-
K. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J. Morris, K. Yarasheski, R. Bateman, Decreased clearance of CNS β-amyloid in Alzheimer's disease. Science 330, 1774 (2010).
-
(2010)
Science
, vol.330
, pp. 1774
-
-
Mawuenyega, K.1
Sigurdson, W.2
Ovod, V.3
Munsell, L.4
Kasten, T.5
Morris, J.6
Yarasheski, K.7
Bateman, R.8
-
37
-
-
84863300949
-
Earlyonset familial Alzheimer's disease (EOFAD)
-
L. Wu, P. Rosa-Neto, G. Hsiung, A. Sadovnick, M. Masellis, S. Black, J. Jia, S. Gauthier, Earlyonset familial Alzheimer's disease (EOFAD). Can. J. Neurol. Sci. 39, 436-445 (2012).
-
(2012)
Can. J. Neurol. Sci.
, vol.39
, pp. 436-445
-
-
Wu, L.1
Rosa-Neto, P.2
Hsiung, G.3
Sadovnick, A.4
Masellis, M.5
Black, S.6
Jia, J.7
Gauthier, S.8
-
38
-
-
16044365171
-
The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
-
C. A. Lemere, F. Lopera, K. S. Kosik, C. L. Lendon, J. Ossa, T. C. Saido, H. Yamaguchi, A. Ruiz, A. Martinez, L. Madrigal, L. Hincapie, J. C. Arango, D. C. Anthony, E. H. Koo, A. M. Goate, D. J. Selkoe, J. C. Arango, The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2, 1146-1150 (1996).
-
(1996)
Nat. Med.
, vol.2
, pp. 1146-1150
-
-
Lemere, C.A.1
Lopera, F.2
Kosik, K.S.3
Lendon, C.L.4
Ossa, J.5
Saido, T.C.6
Yamaguchi, H.7
Ruiz, A.8
Martinez, A.9
Madrigal, L.10
Hincapie, L.11
Arango, J.C.12
Anthony, D.C.13
Koo, E.H.14
Goate, A.M.15
Selkoe, D.J.16
Arango, J.C.17
-
39
-
-
9444276544
-
42 (43)
-
42 (43). Ann. Neurol. 40, 149-156 (1996).
-
(1996)
Ann. Neurol.
, vol.40
, pp. 149-156
-
-
Mann, D.1
Iwatsubo, T.2
Cairns, N.J.3
Lantos, P.L.4
Nochlin, D.5
Sumi, S.M.6
Bird, T.D.7
Poorkaj, P.8
Hardy, J.9
Hutton, M.10
Prihar, G.11
Crook, R.12
Rossor, M.N.13
Haltia, M.14
-
40
-
-
0037044295
-
Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities
-
S. O'Riordan, P. McMonagle, J. Janssen, N. Fox, M. Farrell, J. Collinge, M. Rossor, M. Hutchinson, Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology 59, 1108-1110 (2002).
-
(2002)
Neurology
, vol.59
, pp. 1108-1110
-
-
O'Riordan, S.1
McMonagle, P.2
Janssen, J.3
Fox, N.4
Farrell, M.5
Collinge, J.6
Rossor, M.7
Hutchinson, M.8
-
41
-
-
57649165532
-
Histopathological and molecular heterogeneity among individuals with dementia associated with presenilin mutations
-
C. Maarouf, I. Daugs, S. Spina, R. Vidal, T. Kokjohn, R. Patton, W. Kalback, D. Luehrs, D. Walker, E. Castaño, T. Beach, B. Ghetti, A. Roher, Histopathological and molecular heterogeneity among individuals with dementia associated with presenilin mutations. Mol. Neurodegener. 3, 20 (2008).
-
(2008)
Mol. Neurodegener.
, vol.3
, pp. 20
-
-
Maarouf, C.1
Daugs, I.2
Spina, S.3
Vidal, R.4
Kokjohn, T.5
Patton, R.6
Kalback, W.7
Luehrs, D.8
Walker, D.9
Castaño, E.10
Beach, T.11
Ghetti, B.12
Roher, A.13
-
42
-
-
18344417178
-
Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
-
C. Lippa, H. Fujiwara, D. Mann, B. Giasson, M. Baba, M. Schmidt, L. Nee, B. O'Connell, D. Pollen, P. S. George-Hyslop, B. Ghetti, D. Nochlin, T. Bird, N. Cairns, V. Lee, T. Iwatsubo, J. Trojanowski, Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365-1370 (1998).
-
(1998)
Am. J. Pathol.
, vol.153
, pp. 1365-1370
-
-
Lippa, C.1
Fujiwara, H.2
Mann, D.3
Giasson, B.4
Baba, M.5
Schmidt, M.6
Nee, L.7
O'Connell, B.8
Pollen, D.9
George-Hyslop, P.S.10
Ghetti, B.11
Nochlin, D.12
Bird, T.13
Cairns, N.14
Lee, V.15
Iwatsubo, T.16
Trojanowski, J.17
-
43
-
-
1342344129
-
Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations
-
A. Lleó, O. Berezovska, J. Growdon, B. Hyman, Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am. J. Geriatr. Psychiatry 12, 146-156 (2004).
-
(2004)
Am. J. Geriatr. Psychiatry
, vol.12
, pp. 146-156
-
-
Lleó, A.1
Berezovska, O.2
Growdon, J.3
Hyman, B.4
-
44
-
-
84869126018
-
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study
-
E. Reiman, Y. Quiroz, A. Fleisher, K. Chen, C. Velez-Pardo, M. Jimenez-Del-Rio, A. Fagan, A. Shah, S. Alvarez, A. Arbelaez, M. Giraldo, N. Acosta-Baena, R. Sperling, B. Dickerson, C. Stern, V. Tirado, C. Munoz, R. Reiman, M. Huentelman, G. Alexander, J. Langbaum, K. Kosik, P. Tariot, F. Lopera, Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol. 11, 1048-1056 (2012).
-
(2012)
Lancet Neurol.
, vol.11
, pp. 1048-1056
-
-
Reiman, E.1
Quiroz, Y.2
Fleisher, A.3
Chen, K.4
Velez-Pardo, C.5
Jimenez-Del-Rio, M.6
Fagan, A.7
Shah, A.8
Alvarez, S.9
Arbelaez, A.10
Giraldo, M.11
Acosta-Baena, N.12
Sperling, R.13
Dickerson, B.14
Stern, C.15
Tirado, V.16
Munoz, C.17
Reiman, R.18
Huentelman, M.19
Alexander, G.20
Langbaum, J.21
Kosik, K.22
Tariot, P.23
Lopera, F.24
more..
-
45
-
-
0025239838
-
Cerebrospinal fluid production is reduced in healthy aging
-
C. May, J. Kaye, J. Atack, M. Schapiro, R. Friedland, S. Rapoport, Cerebrospinal fluid production is reduced in healthy aging. Neurology 40, 500-503 (1990).
-
(1990)
Neurology
, vol.40
, pp. 500-503
-
-
May, C.1
Kaye, J.2
Atack, J.3
Schapiro, M.4
Friedland, R.5
Rapoport, S.6
-
46
-
-
49349092320
-
PET imaging of amyloid deposition in patients with mild cognitive impairment
-
A. Forsberg, H. Engler, O. Almkvist, G. Blomquist, G. Hagman, A. Wall, A. Ringheim, B. Langström, A. Nordberg, PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol. Aging 29, 1456-1465 (2008).
-
(2008)
Neurobiol. Aging
, vol.29
, pp. 1456-1465
-
-
Forsberg, A.1
Engler, H.2
Almkvist, O.3
Blomquist, G.4
Hagman, G.5
Wall, A.6
Ringheim, A.7
Langström, B.8
Nordberg, A.9
-
47
-
-
77949425172
-
181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
-
181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease. EMBO Mol. Med. 1, 371-380 (2009).
-
(2009)
EMBO Mol. Med.
, vol.1
, pp. 371-380
-
-
Fagan, A.1
Mintun, M.2
Shah, A.3
Aldea, P.4
Roe, C.5
Mach, R.6
Marcus, D.7
Morris, J.8
Holtzman, D.9
-
48
-
-
35648938247
-
Increase in β-amyloid levels in cerebrospinal fluid of children with Down syndrome
-
H. Englund, G. Annerén, J. Gustafsson, U. Wester, J. Wiltfang, L. Lannfelt, K. Blennow, K. Höglund, Increase in β-amyloid levels in cerebrospinal fluid of children with Down syndrome. Dement. Geriatr. Cogn. Disord. 24, 369-374 (2007).
-
(2007)
Dement. Geriatr. Cogn. Disord.
, vol.24
, pp. 369-374
-
-
Englund, H.1
Annerén, G.2
Gustafsson, J.3
Wester, U.4
Wiltfang, J.5
Lannfelt, L.6
Blennow, K.7
Höglund, K.8
-
49
-
-
0035836622
-
ZCSF tau and Aβ42 levels in patients with Down's syndrome
-
T. Tapiola, H. Soininen, T. Pirttilä, ZCSF tau and Aβ42 levels in patients with Down's syndrome. Neurology 56, 979-980 (2001).
-
(2001)
Neurology
, vol.56
, pp. 979-980
-
-
Tapiola, T.1
Soininen, H.2
Pirttilä, T.3
-
50
-
-
16044373524
-
Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
-
D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, S. Younkin, Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870 (1996).
-
(1996)
Nat. Med.
, vol.2
, pp. 864-870
-
-
Scheuner, D.1
Eckman, C.2
Jensen, M.3
Song, X.4
Citron, M.5
Suzuki, N.6
Bird, T.7
Hardy, J.8
Hutton, M.9
Kukull, W.10
Larson, E.11
Levy-Lahad, E.12
Viitanen, M.13
Peskind, E.14
Poorkaj, P.15
Schellenberg, G.16
Tanzi, R.17
Wasco, W.18
Lannfelt, L.19
Selkoe, D.20
Younkin, S.21
more..
-
51
-
-
77949423619
-
Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease
-
K. Blennow, H. Hampel, M. Weiner, H. Zetterberg, Cerebrospinal fluid and plasma biomarkers in Alzheimer's disease. Nat. Rev. Neurol. 6, 131-144 (2010).
-
(2010)
Nat. Rev. Neurol.
, vol.6
, pp. 131-144
-
-
Blennow, K.1
Hampel, H.2
Weiner, M.3
Zetterberg, H.4
-
52
-
-
79952793175
-
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
-
D. Prvulovic, H. Hampel, Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Clin. Chem. Lab. Med. 49, 367-374 (2011).
-
(2011)
Clin. Chem. Lab. Med.
, vol.49
, pp. 367-374
-
-
Prvulovic, D.1
Hampel, H.2
-
53
-
-
47549117283
-
Biochemical markers in persons with preclinical familial Alzheimer disease
-
J. Ringman, S. Younkin, D. Pratico, W. Seltzer, G. Cole, D. Geschwind, Y. Rodriguez-Agudelo, B. Schaffer, J. Fein, S. Sokolow, E. Rosario, K. Gylys, A. Varpetian, L. Medina, J. Cummings, Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71, 85-92 (2008).
-
(2008)
Neurology
, vol.71
, pp. 85-92
-
-
Ringman, J.1
Younkin, S.2
Pratico, D.3
Seltzer, W.4
Cole, G.5
Geschwind, D.6
Rodriguez-Agudelo, Y.7
Schaffer, B.8
Fein, J.9
Sokolow, S.10
Rosario, E.11
Gylys, K.12
Varpetian, A.13
Medina, L.14
Cummings, J.15
-
54
-
-
54049133348
-
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients
-
J. Lee, K. Blennow, N. Andreasen, O. Laterza, V. Modur, J. Olander, F. Gao, M. Ohlendorf, J. Ladenson, The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. Clin. Chem. 54, 1617-1623 (2008).
-
(2008)
Clin. Chem.
, vol.54
, pp. 1617-1623
-
-
Lee, J.1
Blennow, K.2
Andreasen, N.3
Laterza, O.4
Modur, V.5
Olander, J.6
Gao, F.7
Ohlendorf, M.8
Ladenson, J.9
-
55
-
-
80051481026
-
Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer's disease
-
R. Tarawneh, G. D'Angelo, E. Macy, C. Xiong, D. Carter, N. Cairns, A. Fagan, M. Mintun, J. Ladenson, J.-M. Lee, J. Morris, D. Holtzman, Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer's disease. Ann. Neurol. 70, 274-285 (2011).
-
(2011)
Ann. Neurol.
, vol.70
, pp. 274-285
-
-
Tarawneh, R.1
D'Angelo, G.2
Macy, E.3
Xiong, C.4
Carter, D.5
Cairns, N.6
Fagan, A.7
Mintun, M.8
Ladenson, J.9
Lee, J.-M.10
Morris, J.11
Holtzman, D.12
-
56
-
-
33748300597
-
Identification of novel brain biomarkers
-
O. Laterza, V. Modur, D. Crimmins, J. Olander, Y. Landt, J. Lee, J. Ladenson, Identification of novel brain biomarkers. Clin. Chem. 52, 1713-1721 (2006).
-
(2006)
Clin. Chem.
, vol.52
, pp. 1713-1721
-
-
Laterza, O.1
Modur, V.2
Crimmins, D.3
Olander, J.4
Landt, Y.5
Lee, J.6
Ladenson, J.7
-
57
-
-
84860832253
-
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
-
R. Tarawneh, J. Lee, J. Ladenson, J. Morris, D. Holtzman, CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology 10, 709-719 (2012).
-
(2012)
Neurology
, vol.10
, pp. 709-719
-
-
Tarawneh, R.1
Lee, J.2
Ladenson, J.3
Morris, J.4
Holtzman, D.5
-
58
-
-
34247893817
-
Longitudinal stability of CSF biomarkers in Alzheimer's disease
-
K. Blennow, H. Zetterberg, L. Minthon, L. Lannfelt, S. Strid, P. Annas, H. Basun, N. Andreasen, Longitudinal stability of CSF biomarkers in Alzheimer's disease. Neurosci. Lett. 419, 18-22 (2007).
-
(2007)
Neurosci. Lett.
, vol.419
, pp. 18-22
-
-
Blennow, K.1
Zetterberg, H.2
Minthon, L.3
Lannfelt, L.4
Strid, S.5
Annas, P.6
Basun, H.7
Andreasen, N.8
-
59
-
-
36549078600
-
Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years
-
H. Zetterberg, M. Pedersen, K. Lind, M. Svensson, S. Rolstad, C. Eckerström, S. Syversen, U. Mattsson, C. Ysander, N. Mattsson, A. Nordlund, H. Vanderstichele, E. Vanmechelen, M. Jonsson, A. Edman, K. Blennow, A. Wallin, Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. J. Alzheimers Dis. 12, 255-260 (2007).
-
(2007)
J. Alzheimers Dis.
, vol.12
, pp. 255-260
-
-
Zetterberg, H.1
Pedersen, M.2
Lind, K.3
Svensson, M.4
Rolstad, S.5
Eckerström, C.6
Syversen, S.7
Mattsson, U.8
Ysander, C.9
Mattsson, N.10
Nordlund, A.11
Vanderstichele, H.12
Vanmechelen, E.13
Jonsson, M.14
Edman, A.15
Blennow, K.16
Wallin, A.17
-
60
-
-
77955474927
-
Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
-
L. A. Beckett, D. J. Harvey, A. Gamst, M. Donohue, J. Kornak, H. Zhang, J. H. Kuo; Alzheimer's Disease Neuroimaging Initiative, The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimers Dement. 6, 257-264 (2010).
-
(2010)
Alzheimers Dement.
, vol.6
, pp. 257-264
-
-
Beckett, L.A.1
Harvey, D.J.2
Gamst, A.3
Donohue, M.4
Kornak, J.5
Zhang, H.6
Kuo, J.H.7
-
61
-
-
76149101242
-
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults
-
E. Stomrud, O. Hansson, H. Zetterberg, K. Blennow, L. Minthon, E. Londos, Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults. Arch. Neurol. 67, 217-223 (2010).
-
(2010)
Arch. Neurol.
, vol.67
, pp. 217-223
-
-
Stomrud, E.1
Hansson, O.2
Zetterberg, H.3
Blennow, K.4
Minthon, L.5
Londos, E.6
-
62
-
-
77954706306
-
Alzheimer's Disease Neuroimaging Initiative, Serial MRI and CSF biomarkers in normal aging, MCI, and AD
-
P. Vemuri, H. J. Wiste, S. D. Weigand, D. S. Knopman, J. Q. Trojanowski, L. M. Shaw, M. A. Bernstein, P. S. Aisen, M. Weiner, R. C. Petersen, C. R. Jack Jr.; Alzheimer's Disease Neuroimaging Initiative, Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology 75, 143-151 (2010).
-
(2010)
Neurology
, vol.75
, pp. 143-151
-
-
Vemuri, P.1
Wiste, H.J.2
Weigand, S.D.3
Knopman, D.S.4
Trojanowski, J.Q.5
Shaw, L.M.6
Bernstein, M.A.7
Aisen, P.S.8
Weiner, M.9
Petersen, R.C.10
Jack Jr., C.R.11
-
63
-
-
0030599039
-
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up
-
M. Blomberg, M. Jensen, H. Basun, L. Lannfelt, L. Wahlund, Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ε4 during 14 months follow-up. Neurosci. Lett. 214, 163-166 (1996).
-
(1996)
Neurosci. Lett.
, vol.214
, pp. 163-166
-
-
Blomberg, M.1
Jensen, M.2
Basun, H.3
Lannfelt, L.4
Wahlund, L.5
-
64
-
-
0032821266
-
Longitudinal stability of CSF tau levels in Alzheimer patients
-
T. Sunderland, B. Wolozin, D. Galasko, J. Levy, R. Dukoff, M. Bahro, R. Lasser, R. Motter, T. Lehtimäki, P. Seubert, Longitudinal stability of CSF tau levels in Alzheimer patients. Biol. Psychiatry 46, 750-755 (1999).
-
(1999)
Biol. Psychiatry
, vol.46
, pp. 750-755
-
-
Sunderland, T.1
Wolozin, B.2
Galasko, D.3
Levy, J.4
Dukoff, R.5
Bahro, M.6
Lasser, R.7
Motter, R.8
Lehtimäki, T.9
Seubert, P.10
-
65
-
-
14444269228
-
Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42 (43) in Alzheimer's disease: A study in Japan
-
M. Kanai, E. Matsubara, K. Isoe, K. Urakami, K. Nakashima, H. Arai, H. Sasaki, K. Abe, T. Iwatsubo, T. Kosaka, M. Watanabe, Y. Tomidokoro, M. Shizuka, K. Mizushima, T. Nakamura, Y. Igeta, Y. Ikeda, M. Amari, T. Kawarabayashi, K. Ishiguro, Y. Harigaya, K. Wakabayashi, K. Okamoto, S. Hirai, M. Shoji, Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42 (43) in Alzheimer's disease: A study in Japan. Ann. Neurol. 44, 17-26 (1998).
-
(1998)
Ann. Neurol.
, vol.44
, pp. 17-26
-
-
Kanai, M.1
Matsubara, E.2
Isoe, K.3
Urakami, K.4
Nakashima, K.5
Arai, H.6
Sasaki, H.7
Abe, K.8
Iwatsubo, T.9
Kosaka, T.10
Watanabe, M.11
Tomidokoro, Y.12
Shizuka, M.13
Mizushima, K.14
Nakamura, T.15
Igeta, Y.16
Ikeda, Y.17
Amari, M.18
Kawarabayashi, T.19
Ishiguro, K.20
Harigaya, Y.21
Wakabayashi, K.22
Okamoto, K.23
Hirai, S.24
Shoji, M.25
more..
-
66
-
-
0033953722
-
Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease
-
T. Tapiola, T. Pirttilä, M. Mikkonen, P. Mehta, I. Alafuzoff, K. Koivisto, H. Soininen, Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease. Neurosci. Lett. 280, 119-122 (2000).
-
(2000)
Neurosci. Lett.
, vol.280
, pp. 119-122
-
-
Tapiola, T.1
Pirttilä, T.2
Mikkonen, M.3
Mehta, P.4
Alafuzoff, I.5
Koivisto, K.6
Soininen, H.7
-
67
-
-
0032821266
-
Longitudinal stability of CSF tau levels in Alzheimer's patients
-
T. Sunderland, B. Woolozin, D. Galasko, J. Levy, R. Dukoff, M. Bahro, R. Lasser, R. Motter, T. Lehtimäki, P. Seubert, Longitudinal stability of CSF tau levels in Alzheimer's patients. Biol. Psychiatry 46, 750-755 (1999).
-
(1999)
Biol. Psychiatry
, vol.46
, pp. 750-755
-
-
Sunderland, T.1
Woolozin, B.2
Galasko, D.3
Levy, J.4
Dukoff, R.5
Bahro, M.6
Lasser, R.7
Motter, R.8
Lehtimäki, T.9
Seubert, P.10
-
68
-
-
84888201046
-
Longitudinal change in CSF tau and Aβ biomarkers for up to 48 months in ADNI
-
J. Toledo, S. Xie, T. Trojanowski, L. Shaw, Longitudinal change in CSF tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol. 126, 659-670 (2013).
-
(2013)
Acta Neuropathol.
, vol.126
, pp. 659-670
-
-
Toledo, J.1
Xie, S.2
Trojanowski, T.3
Shaw, L.4
-
69
-
-
80052846251
-
Longitudinal changes of CSF biomarkers in Alzheimer's disease
-
T. Seppälä, A. Koivisto, P. Hartikainen, S. Helisalmi, H. Soininen, S. Herukka, Longitudinal changes of CSF biomarkers in Alzheimer's disease. J. Alzheimers Dis. 25, 583-594 (2011).
-
(2011)
J. Alzheimers Dis.
, vol.25
, pp. 583-594
-
-
Seppälä, T.1
Koivisto, A.2
Hartikainen, P.3
Helisalmi, S.4
Soininen, H.5
Herukka, S.6
-
70
-
-
79959676662
-
Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation
-
J. Ringman, K. Taylor, E. Teng, G. Coppola, K. Gylys, Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation. Neurology 76, 2124-2125 (2011).
-
(2011)
Neurology
, vol.76
, pp. 2124-2125
-
-
Ringman, J.1
Taylor, K.2
Teng, E.3
Coppola, G.4
Gylys, K.5
-
71
-
-
84878317303
-
Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/ Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations
-
M. Ikeda, K. Yonemura, S. Kakuda, Y. Tashiro, Y. Fujita, E. Takai, Y. Hashimoto, K. Makioka, N. Furuta, K. Ishiguro, R. Maruki, J. Yoshida, O. Miyaguchi, T. Tsukie, R. Kuwano, T. Yamazaki, H. Yamaguchi, M. Amari, M. Takatama, Y. Harigaya, K. Okamoto, Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations. Amyloid 20, 107-112 (2013).
-
(2013)
Amyloid
, vol.20
, pp. 107-112
-
-
Ikeda, M.1
Yonemura, K.2
Kakuda, S.3
Tashiro, Y.4
Fujita, Y.5
Takai, E.6
Hashimoto, Y.7
Makioka, K.8
Furuta, N.9
Ishiguro, K.10
Maruki, R.11
Yoshida, J.12
Miyaguchi, O.13
Tsukie, T.14
Kuwano, R.15
Yamazaki, T.16
Yamaguchi, H.17
Amari, M.18
Takatama, M.19
Harigaya, Y.20
Okamoto, K.21
more..
-
72
-
-
0027749448
-
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
-
J. Morris, S. Edland, C. Clark, D. Galasko, E. Koss, R. Mohs, G. Van Belle, G. Fillenbaum, A. Heyman, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43, 2457-2465 (1993).
-
(1993)
Neurology
, vol.43
, pp. 2457-2465
-
-
Morris, J.1
Edland, S.2
Clark, C.3
Galasko, D.4
Koss, E.5
Mohs, R.6
Van Belle, G.7
Fillenbaum, G.8
Heyman, A.9
-
73
-
-
0141529993
-
In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life
-
J. Cirrito, P. May, M. O'Dell, J. Taylor, M. Parsadanian, J. Cramer, J. Audia, J. Nissen, K. Bales, S. Paul, R. DeMattos, D. Holtzman, In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life. J. Neurosci. 23, 8844-8853 (2003).
-
(2003)
J. Neurosci.
, vol.23
, pp. 8844-8853
-
-
Cirrito, J.1
May, P.2
O'Dell, M.3
Taylor, J.4
Parsadanian, M.5
Cramer, J.6
Audia, J.7
Nissen, J.8
Bales, K.9
Paul, S.10
De Mattos, R.11
Holtzman, D.12
-
74
-
-
80155148102
-
Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formation
-
S. Hong, O. Quintero-Monzon, B. Ostaszewski, D. Podlisny, W. Cavanaugh, T. Yang, D. Holtzman, J. Cirrito, D. Selkoe, Dynamic analysis of amyloid β-protein in behaving mice reveals opposing changes in ISF versus parenchymal Aβ during age-related plaque formation. J. Neurosci. 31, 15861-15869 (2011).
-
(2011)
J. Neurosci.
, vol.31
, pp. 15861-15869
-
-
Hong, S.1
Quintero-Monzon, O.2
Ostaszewski, B.3
Podlisny, D.4
Cavanaugh, W.5
Yang, T.6
Holtzman, D.7
Cirrito, J.8
Selkoe, D.9
-
75
-
-
81755177047
-
Alzheimer's Disease Neuroimaging Initiative, Evidence for ordering of Alzheimer disease biomarkers
-
C. R. Jack Jr., P. Vemuri, H. J. Wiste, S. D. Weigand, P. S. Aisen, J. Q. Trojanowski, L. M. Shaw, M. A. Bernstein, R. C. Petersen, M. W. Weiner, D. S. Knopman; Alzheimer's Disease Neuroimaging Initiative, Evidence for ordering of Alzheimer disease biomarkers. Arch. Neurol. 68, 1526-1535 (2011).
-
(2011)
Arch. Neurol.
, vol.68
, pp. 1526-1535
-
-
Jack Jr., C.R.1
Vemuri, P.2
Wiste, H.J.3
Weigand, S.D.4
Aisen, P.S.5
Trojanowski, J.Q.6
Shaw, L.M.7
Bernstein, M.A.8
Petersen, R.C.9
Weiner, M.W.10
Knopman, D.S.11
-
76
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
R. Sperling, P. Aisen, L. Beckett, D. Bennett, S. Craft, A. Fagan, T. Iwatsubo, C. Jack, J. Kaye, T. Montine, D. Park, E. Reiman, C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M. Carrillo, W. Thies, M. Morrison-Bogorad, M. Wagster, C. Phelps, Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292 (2011).
-
(2011)
Alzheimers Dement.
, vol.7
, pp. 280-292
-
-
Sperling, R.1
Aisen, P.2
Beckett, L.3
Bennett, D.4
Craft, S.5
Fagan, A.6
Iwatsubo, T.7
Jack, C.8
Kaye, J.9
Montine, T.10
Park, D.11
Reiman, E.12
Rowe, C.13
Siemers, E.14
Stern, Y.15
Yaffe, K.16
Carrillo, M.17
Thies, W.18
Morrison-Bogorad, M.19
Wagster, M.20
Phelps, C.21
more..
-
77
-
-
0141751616
-
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study
-
D. Chan, J. Janssen, J. Whitwell, H. Watt, R. Jenkins, C. Frost, M. Rossor, N. Fox, Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: Longitudinal MRI study. Lancet 362, 1121-1122 (2003).
-
(2003)
Lancet
, vol.362
, pp. 1121-1122
-
-
Chan, D.1
Janssen, J.2
Whitwell, J.3
Watt, H.4
Jenkins, R.5
Frost, C.6
Rossor, M.7
Fox, N.8
-
78
-
-
43249097282
-
Atrophy rates accelerate in amnestic mild cognitive impairment
-
C. Jack, S. Weigand, M. Shiung, S. Przybelski, P. O'Brien, J. Gunter, D. Knopman, B. Boeve, G. Smith, R. Petersen, Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology 70, 1740-1752 (2008).
-
(2008)
Neurology
, vol.70
, pp. 1740-1752
-
-
Jack, C.1
Weigand, S.2
Shiung, M.3
Przybelski, S.4
O'Brien, P.5
Gunter, J.6
Knopman, D.7
Boeve, B.8
Smith, G.9
Petersen, R.10
-
79
-
-
33750594921
-
Tracking atrophy progression in familial Alzheimer's disease: A serial MRI study
-
B. Ridha, J. Barnes, J. Bartlett, A. Godbolt, T. Pepple, M. Rossor, N. Fox, Tracking atrophy progression in familial Alzheimer's disease: A serial MRI study. Lancet Neurol. 5, 828-834 (2006).
-
(2006)
Lancet Neurol.
, vol.5
, pp. 828-834
-
-
Ridha, B.1
Barnes, J.2
Bartlett, J.3
Godbolt, A.4
Pepple, T.5
Rossor, M.6
Fox, N.7
-
80
-
-
80051562627
-
Acceleration of cortical thinning in familial Alzheimer's disease
-
W. Knight, L. Kim, A. Douiri, C. Frost, M. Rossor, N. Fox, Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol. Aging 32, 1765-1773 (2011).
-
(2011)
Neurobiol. Aging
, vol.32
, pp. 1765-1773
-
-
Knight, W.1
Kim, L.2
Douiri, A.3
Frost, C.4
Rossor, M.5
Fox, N.6
-
81
-
-
78651266932
-
Autosomal-dominant Alzheimer's disease: A review and proposal for the prevention of Alzheimer's disease
-
R. Bateman, P. Aisen, B. D. Strooper, N. Fox, C. Lemere, J. Ringman, S. Salloway, R. Sperling, M. Windisch, C. Xiong, Autosomal-dominant Alzheimer's disease: A review and proposal for the prevention of Alzheimer's disease. Alzheimers Res. Ther. 3, 1 (2011).
-
(2011)
Alzheimers Res. Ther.
, vol.3
, pp. 1
-
-
Bateman, R.1
Aisen, P.2
Strooper, B.D.3
Fox, N.4
Lemere, C.5
Ringman, J.6
Salloway, S.7
Sperling, R.8
Windisch, M.9
Xiong, C.10
-
82
-
-
0023944331
-
Validation of clinical diagnostic criteria for Alzheimer's disease
-
J. Morris, D. McKeel, K. Fulling, R. Torack, L. Berg, Validation of clinical diagnostic criteria for Alzheimer's disease. Ann. Neurol. 24, 17-22 (1988).
-
(1988)
Ann. Neurol.
, vol.24
, pp. 17-22
-
-
Morris, J.1
McKeel, D.2
Fulling, K.3
Torack, R.4
Berg, L.5
-
83
-
-
0027425211
-
The Clinical Dementia Rating (CDR): Current version and scoring rules
-
J. C. Morris, The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414 (1993).
-
(1993)
Neurology
, vol.43
, pp. 2412-2414
-
-
Morris, J.C.1
-
84
-
-
14444285507
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype
-
L. Berg, D. W. McKeel, J. P. Miller, M. Storandt, E. H. Rubin, J. C. Morris, J. Baty, M. Coats, J. Norton, A. M. Goate, J. L. Price, M. Gearing, S. S. Mirra, A. M. Saunders, Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch. Neurol. 55, 326-335 (1998).
-
(1998)
Arch. Neurol.
, vol.55
, pp. 326-335
-
-
Berg, L.1
McKeel, D.W.2
Miller, J.P.3
Storandt, M.4
Rubin, E.H.5
Morris, J.C.6
Baty, J.7
Coats, M.8
Norton, J.9
Goate, A.M.10
Price, J.L.11
Gearing, M.12
Mirra, S.S.13
Saunders, A.M.14
-
85
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E. Stadlan, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.6
-
86
-
-
8044226013
-
Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation
-
F. Lopera, A. Ardilla, A. Martínez, L. Madrigal, J. Arango-Viana, C. Lemere, J. Arango-Lasprilla, L. Hincapíe, M. Arcos-Burgos, J. Ossa, I. Behrens, J. Norton, C. Lendon, A. Goate, A. Ruiz-Linares, M. Rosselli, K. Kosik, Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277, 793-799 (1997).
-
(1997)
JAMA
, vol.277
, pp. 793-799
-
-
Lopera, F.1
Ardilla, A.2
Martínez, A.3
Madrigal, L.4
Arango-Viana, J.5
Lemere, C.6
Arango-Lasprilla, J.7
Hincapíe, L.8
Arcos-Burgos, M.9
Ossa, J.10
Behrens, I.11
Norton, J.12
Lendon, C.13
Goate, A.14
Ruiz-Linares, A.15
Rosselli, M.16
Kosik, K.17
-
87
-
-
11244274006
-
APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation
-
E. Wijsman, E. Daw, X. Yu, E. Steinbart, D. Nochlin, T. Bird, G. Schellenberg, APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132 B, 14-20 (2005).
-
(2005)
Am. J. Med. Genet. B Neuropsychiatr. Genet.
, vol.132 B
, pp. 14-20
-
-
Wijsman, E.1
Daw, E.2
Yu, X.3
Steinbart, E.4
Nochlin, D.5
Bird, T.6
Schellenberg, G.7
-
88
-
-
34249949113
-
Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation
-
J. Kauwe, S. Jacquart, S. Chakraverty, J. Wang, K. Mayo, A. Fagan, D. Holtzman, J. Morris, A. Goate, Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation. Ann. Neurol. 61, 446-453 (2007).
-
(2007)
Ann. Neurol.
, vol.61
, pp. 446-453
-
-
Kauwe, J.1
Jacquart, S.2
Chakraverty, S.3
Wang, J.4
Mayo, K.5
Fagan, A.6
Holtzman, D.7
Morris, J.8
Goate, A.9
-
89
-
-
79958102380
-
Alzheimer's Disease Neuroimaging Initiative, Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
-
L. M. Shaw, H. Vanderstichele, M. Knapik-Czajka, M. Figurski, E. Coart, K. Blennow, H. Soares, A. J. Simon, P. Lewczuk, R. A. Dean, E. Siemers, W. Potter, V. M. Lee, J. Q. Trojanowski; Alzheimer's Disease Neuroimaging Initiative, Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol. 121, 597-609 (2011).
-
(2011)
Acta Neuropathol.
, vol.121
, pp. 597-609
-
-
Shaw, L.M.1
Vanderstichele, H.2
Knapik-Czajka, M.3
Figurski, M.4
Coart, E.5
Blennow, K.6
Soares, H.7
Simon, A.J.8
Lewczuk, P.9
Dean, R.A.10
Siemers, E.11
Potter, W.12
Lee, V.M.13
Trojanowski, J.Q.14
-
90
-
-
33750455449
-
CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies
-
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, C. Trenkwalder, P. Brechlin, E. Rüther, J. Kornhuber, M. Otto, J. Wiltfang, CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies. J. Neural Transm. 113, 1771-1718 (2006).
-
(2006)
J. Neural Transm.
, vol.113
, pp. 1771-1718
-
-
Bibl, M.1
Mollenhauer, B.2
Esselmann, H.3
Lewczuk, P.4
Trenkwalder, C.5
Brechlin, P.6
Rüther, E.7
Kornhuber, J.8
Otto, M.9
Wiltfang, J.10
-
91
-
-
33845713197
-
(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies
-
(181P) assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin. Chem. Lab. Med. 44, 1472-1480 (2006).
-
(2006)
Clin. Chem. Lab. Med.
, vol.44
, pp. 1472-1480
-
-
Vanderstichele, H.1
Vreese, K.D.2
Blennow, K.3
Andreasen, N.4
Sindic, C.5
Ivanoiu, A.6
Hampel, H.7
Bürger, K.8
Parnetti, L.9
Lanari, A.10
Padovani, A.11
Di Luca, M.12
Bläser, M.13
Olsson, A.14
Pottel, H.15
Hulstaert, F.16
Vanmechelen, E.17
-
92
-
-
33947223454
-
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
-
A. Fagan, C. Roe, C. Xiong, M. Mintun, J. Morris, D. Holtzman, Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64, 343-349 (2007).
-
(2007)
Arch. Neurol.
, vol.64
, pp. 343-349
-
-
Fagan, A.1
Roe, C.2
Xiong, C.3
Mintun, M.4
Morris, J.5
Holtzman, D.6
-
93
-
-
44949219321
-
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
-
S. Engelborghs, K. De Vreese, T. Van De Casteele, H. Vanderstichele, B. Van Everbroeck, P. Cras, J. Martin, E. Vanmechelen, P. De Deyn, Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 29, 1143-1159 (2008).
-
(2008)
Neurobiol. Aging
, vol.29
, pp. 1143-1159
-
-
Engelborghs, S.1
De Vreese, K.2
Van De Casteele, T.3
Vanderstichele, H.4
Van Everbroeck, B.5
Cras, P.6
Martin, J.7
Vanmechelen, E.8
De Deyn, P.9
-
94
-
-
70349884191
-
CSF biomarker levels in early and late onset Alzheimer's disease
-
F. Bouwman, N. Schoonenboom, N. Verwey, E. Van Elk, A. Kok, M. Blankenstein, P. Scheltens, W. Van Der Flier, CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol. Aging 30, 1895-1901 (2009).
-
(2009)
Neurobiol. Aging
, vol.30
, pp. 1895-1901
-
-
Bouwman, F.1
Schoonenboom, N.2
Verwey, N.3
Van Elk, E.4
Kok, A.5
Blankenstein, M.6
Scheltens, P.7
Van Der Flier, W.8
-
95
-
-
67651204382
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
-
N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S. Herukka, W. Van Der Flier, M. Blankenstein, M. Ewers, K. Rich, E. Kaiser, M. Verbeek, M. Tsolaki, E. Mulugeta, E. Rosén, D. Aarsland, P. Visser, J. Schröder, J. Marcusson, M. De Leon, H. Hampel, P. Scheltens, T. Pirttilä, A. Wallin, M. Jönhagen, L. Minthon, B. Winblad, K. Blennow, CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393 (2009).
-
(2009)
JAMA
, vol.302
, pp. 385-393
-
-
Mattsson, N.1
Zetterberg, H.2
Hansson, O.3
Andreasen, N.4
Parnetti, L.5
Jonsson, M.6
Herukka, S.7
Van Der Flier, W.8
Blankenstein, M.9
Ewers, M.10
Rich, K.11
Kaiser, E.12
Verbeek, M.13
Tsolaki, M.14
Mulugeta, E.15
Rosén, E.16
Aarsland, D.17
Visser, P.18
Schröder, J.19
Marcusson, J.20
De Leon, M.21
Hampel, H.22
Scheltens, P.23
Pirttilä, T.24
Wallin, A.25
Jönhagen, M.26
Minthon, L.27
Winblad, B.28
Blennow, K.29
more..
-
96
-
-
67649628753
-
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study
-
P. Visser, F. Verhey, D. Knol, P. Scheltens, L. Wahlund, Y. Freund-Levi, M. Tsolaki, L. Minthon, A. Wallin, H. Hampel, K. Bürger, T. Pirttila, H. Soininen, M. Rikkert, M. Verbeek, L. Spiru, K. Blennow, Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol. 8, 619-627 (2009).
-
(2009)
Lancet Neurol.
, vol.8
, pp. 619-627
-
-
Visser, P.1
Verhey, F.2
Knol, D.3
Scheltens, P.4
Wahlund, L.5
Freund-Levi, Y.6
Tsolaki, M.7
Minthon, L.8
Wallin, A.9
Hampel, H.10
Bürger, K.11
Pirttila, T.12
Soininen, H.13
Rikkert, M.14
Verbeek, M.15
Spiru, L.16
Blennow, K.17
-
97
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
-
W. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D. Holt, M. Bergström, I. Savitcheva, G.-F. Huang, S. Estrada, B. Ausén, M. Debnath, J. Barletta, J. Price, J. Sandell, B. Lopresti, A. Wall, P. Koivisto, G. Antoni, C. Mathis, B. Lȧngström, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306-319 (2004).
-
(2004)
Ann. Neurol.
, vol.55
, pp. 306-319
-
-
Klunk, W.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.6
Bergström, M.7
Savitcheva, I.8
Huang, G.-F.9
Estrada, S.10
Ausén, B.11
Debnath, M.12
Barletta, J.13
Price, J.14
Sandell, J.15
Lopresti, B.16
Wall, A.17
Koivisto, P.18
Antoni, G.19
Mathis, C.20
Langström, B.21
more..
-
98
-
-
33747048954
-
11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
-
11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452 (2006).
-
(2006)
Neurology
, vol.67
, pp. 446-452
-
-
Mintun, M.1
La Rossa, G.2
Sheline, Y.3
Dence, C.4
Lee, S.-Y.5
Mach, R.6
Klunk, W.7
Mathis, C.8
De Kosky, S.9
Morris, J.10
-
99
-
-
0031955835
-
Correction for partial volume effects in PET: Principle and validation
-
O. G. Rousset, Y. Ma, A. C. Evans, Correction for partial volume effects in PET: Principle and validation. J. Nuclear Med. 39, 904-911 (1998).
-
(1998)
J. Nuclear Med.
, vol.39
, pp. 904-911
-
-
Rousset, O.G.1
Ma, Y.2
Evans, A.C.3
-
100
-
-
0001138328
-
Algorithm AS 136: A K-means clustering algorithm
-
J. Hartigan, M. Wong, Algorithm AS 136: A K-means clustering algorithm. J. R. Stat. Soc. Ser. C 28, 100-108 (1979).
-
(1979)
J. R. Stat. Soc. Ser. C
, vol.28
, pp. 100-108
-
-
Hartigan, J.1
Wong, M.2
-
103
-
-
0002552781
-
-
S, J. Chambers, T. Hastie, Eds. Chapman and Hall, New York
-
W. Cleveland, E. Grosse, W. Shyu, in Statistical Models in S, J. Chambers, T. Hastie, Eds. (Chapman and Hall, New York, 1992), pp. 309-376.
-
(1992)
Statistical Models
, pp. 309-376
-
-
Cleveland, W.1
Grosse, E.2
Shyu, W.3
-
104
-
-
0030880605
-
Small sample inference for fixed effects from restricted maximum likelihood
-
M. Kenward, J. Roger, Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53, 983-997 (1997).
-
(1997)
Biometrics
, vol.53
, pp. 983-997
-
-
Kenward, M.1
Roger, J.2
|